Literature DB >> 8363598

Unique preS sequence in a gibbon-derived hepatitis B virus variant.

L T Mimms1, L R Solomon, J W Ebert, H Fields.   

Abstract

A unique hepatitis B virus (HBV) variant has been identified in a gibbon (Hylobates lar) which could be passed to a chimpanzee by experimental inoculation. This HBV variant had been shown to have no reactivity to a monoclonal anti-preS2 antibody (preS2 mAb 116-34) differentiating it from all human HBV specimens tested. This gibbon sera also was not recognized by an anti-preS1 mAb which binds the preS1 hepatocyte receptor region, amino acids 27-35. In this paper, we report the DNA sequence of the gibbon HBV PreS gene. The lack of preS2 mAb (116-34) binding can be explained by a unique nucleotide substitution of A for C in the second codon of the preS2 region leading to the replacement of glutamine with lysine. Two other unique changes were observed at the seventh and 24th amino acid positions in the preS2 gene leading to a substitution of a valine for threonine and alanine, respectively. Unlike all human derived HBV sequences in the preS1 region, the gibbon HBV had a glutamic acid instead of an aspartic acid at amino acid residue 27. Another unique substitution was a leucine for alanine at preS1 position 33. These amino acid changes in the gibbon HBV may explain its unique preS mAb reactivity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8363598     DOI: 10.1006/bbrc.1993.2028

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Molecular epidemiology of hepatitis B virus variants in nonhuman primates.

Authors:  S Grethe; J O Heckel; W Rietschel; F T Hufert
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Complete nucleotide sequence and phylogenetic analyses of hepatitis B virus isolated from two pileated gibbons.

Authors:  Naoto Aiba; Hiroyuki Nishimura; Yasuyuki Arakawa; Kenji Abe
Journal:  Virus Genes       Date:  2003-12       Impact factor: 2.332

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.